$2.17
-0.08-3.56%
Last update: Oct 12, 7:52 PM
$2.20
-0.0493-2.19%
Nautilus Biotechnology Inc (NAUT) Stock Price, Quote, News & History
NAUTNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Nautilus Biotechnology (NASDAQ:NAUT) through any online brokerage.
Other companies in Nautilus Biotechnology’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), IQVIA Holdings Inc (NYSE:IQV) and Waters Corp (NYSE:WAT).
Nautilus Biotechnology has a consensus price target of $3.25.
The stock price for Nautilus Biotechnology (NASDAQ: NAUT) is $2.2007 last updated October 12, 2026 at 7:52 PM EDT.
There are no upcoming dividends for Nautilus Biotechnology.
Nautilus Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for Nautilus Biotechnology.
Nautilus Biotechnology is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the...
